Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Neurology|June 25, 2010
Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studiesC Paradas, J Llauger, J Diaz-Manera, et al.Blood|March 10, 2001
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivoF Lluís, J Roma, M Suelves, et al.European Journal of Neurology|June 3, 2015
The expanding field of IgG4-mediated neurological autoimmune disordersM G Huijbers, L A Querol, E H Niks, et al.Annals of Neurology|August 17, 2001
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyR Hughes, S Bensa, H Willison, et al.Cell Death & Disease|March 3, 2011
Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathyJ Díaz-Manera, T Touvier, A Dellavalle, et al.Neurology|January 6, 2012
Long-lasting treatment effect of rituximab in MuSK myastheniaJ Díaz-Manera, E Martínez-Hernández, L Querol, et al.Journal of Neurology|November 7, 2002
Antidisialosyl antibodies in chronic idiopathic ataxic neuropathyC Serrano-Munuera, R Rojas-García, E Gallardo, et al.Journal of Neuroimmunology|November 6, 2001
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significanceC Serrano-Munuera, E Gallardo, R Rojas, et al.Neuromuscular Disorders : NMD|May 23, 2015
Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohortE Gutiérrez-Rivas, J Bautista, J J Vílchez, et al.Revista De Neurologia|April 12, 2012
Clinical guidelines for late-onset Pompe diseaseM A Barba-Romero, E Barrot, J Bautista-Lorite, et al.Pageof 8